Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered by injection or tablet, helped patients lose a significant amount of ...

Weight loss pill set to rival injections after promising studies The daily tablet has helped patients lose a significant amount of weight in initial studies ...

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.

A diet pill that lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass, could help patients lose weight without suffering brutal side effects.

But a new drug may be able to burn energy, and thus fat, without reducing appetite. In a Phase I trial described in the journal Nature Metabolism, the drug led to statistically significant weight ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...